Eledon Pharmaceuticals Inc
General ticker "ELDN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $230.6M
Eledon Pharmaceuticals Inc follows the US Stock Market performance with the rate: 47.1%.
Estimated limits based on current volatility of 4.5%: low 3.99$, high 4.37$
Factors to consider:
- Current price 71.1% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.82$, 2.45$]
- 2024-12-30 to 2025-12-30 estimated range: [0.94$, 2.62$]
Financial Metrics affecting the ELDN estimates:
- Negative: Non-GAAP EPS, $ of -1.79 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -0.12 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Interest expense per share, $ of 0 <= 0
- Negative: Industry operating profit margin (median), % of -98.30 <= 2.14
Short-term ELDN quotes
Long-term ELDN plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
Operating Expenses | $36.87MM | $88.43MM | $43.00MM |
Operating Income | $-36.87MM | $-88.43MM | $-43.00MM |
Non-Operating Income | $0.01MM | $0.46MM | $2.67MM |
R&D Expense | $23.73MM | $27.08MM | $30.31MM |
Income(Loss) | $-36.86MM | $-87.97MM | $-40.33MM |
Taxes | $-2.35MM | $0.00MM | $0.00MM |
Profit(Loss) | $-34.51MM | $-87.97MM | $-40.33MM |
Stockholders Equity | $164.00MM | $84.18MM | $7.21MM |
Assets | $170.55MM | $92.79MM | $89.07MM |
Operating Cash Flow | $-28.91MM | $-28.42MM | $-39.53MM |
Investing Cash Flow | $0.00MM | $0.00MM | $-45.29MM |
Financing Cash Flow | $-0.45MM | $0.00MM | $33.02MM |
Earnings Per Share* | $-2.33 | $-6.13 | $-0.00 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.